John J. Kirby

Insider Reports History

Entity
Individual
Location
C/O Idera Pharmaceuticals, Inc., 505 Eagleview Blvd., Suite 212, Exton, PA
Signature
/s/ Christopher Hayes, Attorney-in-Fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by John J. Kirby:

Stock Role Class Num Shares Value Price $ Report Date Ownership
Verrica Pharmaceuticals Inc. Interim CFO Common Stock 54.3K $133K $2.46 Nov 6, 2024 Direct
Aceragen, Inc. CHIEF FINANCIAL OFFICER Stock Options (Right to Buy) 25.4K Jan 20, 2023 Direct

Insider Reports Filed by John J. Kirby

Symbol Company Period Transactions Value $ Form Type Date Filed Role
VRCA Verrica Pharmaceuticals Inc. Nov 6, 2024 1 $0 4 Nov 6, 2024 Interim CFO
VRCA Verrica Pharmaceuticals Inc. Nov 5, 2024 0 $0 3 Nov 6, 2024 Interim CFO
ACGN Aceragen, Inc. Jan 20, 2023 1 $0 4 Feb 2, 2023 CHIEF FINANCIAL OFFICER
IDRA IDERA PHARMACEUTICALS, INC. Jan 6, 2023 2 -$85.2K 4 Jan 10, 2023 CHIEF FINANCIAL OFFICER
IDRA IDERA PHARMACEUTICALS, INC. Jul 6, 2022 1 $0 4 Jul 7, 2022 CHIEF FINANCIAL OFFICER
IDRA IDERA PHARMACEUTICALS, INC. Apr 1, 2022 1 $0 4 Apr 4, 2022 CHIEF FINANCIAL OFFICER
IDRA IDERA PHARMACEUTICALS, INC. Jan 24, 2022 1 $0 4 Jan 26, 2022 CHIEF FINANCIAL OFFICER
IDRA IDERA PHARMACEUTICALS, INC. Dec 17, 2021 1 $6.15K 4 Dec 21, 2021 CHIEF FINANCIAL OFFICER
IDRA IDERA PHARMACEUTICALS, INC. Jul 8, 2021 1 $0 4 Jul 12, 2021 CHIEF FINANCIAL OFFICER